Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Leukotriene synthesis inhibitors in development at Bayer

Aug. 5, 1997

Nonpeptide NK3 antagonists from SmithKline Beecham

Aug. 5, 1997

HMR discovers elastase inhibitors and prodrugs thereof

July 31, 1997

Device for snoring cleared by FDA

July 30, 1997

JTV-506 shows potential for asthma

July 30, 1997

Chiroscience reports PDE/TNF inhibitors

July 30, 1997

Sepracor reports promising phase II results for norastemizole

July 29, 1997

Genelabs and UCSF sign agreement for asthma clinical study

July 28, 1997

FDA health advisory for Accolate

July 25, 1997

Piperidone and glutarimide neurokinin antagonists developed at Pfizer

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...